估计免疫球蛋白A肺病的健康状态实用值:时间交易分析
Zheng-Yi Zhou1, Mark E Bensink2, Nisha C Hazra3
1Analysis Group, Boston, MA, USA. jenny.zhou@analysisgroup.com.
PharmacoEconomics - open
|September 21, 2024
概括
免疫球蛋白A脏病 (IgAN) 的健康状态实用值显示,随着疾病的进展显著下降. 这项研究量化了慢性病阶段对生活质量的影响,突出了IgAN的负担.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 卫生经济学 卫生经济学
- 生活质量研究 研究 生命质量研究
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是一种进展性脏疾病,有可能导致功能衰竭.
- 估计健康状态实用值对于理解Igan的社会负担至关重要.
研究的目的:
- 从英国社会角度估计Igan的健康状态实用值.
- 量化IGAN进展对患者生活质量的影响.
主要方法:
- 使用时间权衡 (TTO) 方法来推导效用值.
- 开发了描述IgAN症状和生活质量损害的健康状况图片.
- 通过计算机辅助的电话采访收集了来自英国200名普通公众参与者的数据.
主要成果:
- 随着慢性病 (CKD) 阶段和蛋白尿水平的增加,平均效用值下降.
- 透析 (0.38) 和脏综合征 (0.43) 的CKD5期显示实质上较低的效用值.
- 在所有评估的Igan健康状况中观察到实用性下降.
结论:
- IgAN 的健康状况与健康状况的显著恶化有关.
- 疾病的进展,高蛋白尿和脏综合征导致实质性的效用下降.
- 结果为IGAN干预措施的健康经济评估提供了有价值的数据.
相关概念视频
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...


